Skip to content
Review Open access

A trustworthy cross-domain AI framework for fundus disease classification using hybrid CNN fusion and supervised domain adaptation

Aug 2026 · Discover Artificial Intelligence · Vol 6 · 0 citations · 45 references

TL;DR

FusionEye-Net combines strong internal performance with substantially improved cross-domain generalization through lightweight adaptation, underscoring the critical role of external validation and domain-aware fine-tuning in formulating trustworthy, adaptive AI-assisted decision-support tools that can safely augment automated ophthalmic screening workflows.

Abstract

Deep learning–based systems for fundus disease classification often achieve impressive accuracy on internal datasets, yet their performance degrades markedly when applied to real-world clinical data. This limitation is primarily caused by domain shift arising from variations in imaging devices, illumination conditions, and population characteristics, which remains a key barrier to integrating these technologies into reliable clinical decision-support systems. To address this challenge, we propose FusionEye-Net, a hybrid deep learning framework that performs feature-level fusion of EfficientNet-B3 and ResNet-50 for four-class fundus image classification, namely cataract, diabetic retinopathy, glaucoma, and normal retina. A dedicated preprocessing pipeline—including circular fundus cropping, illumination normalization, contrast-limited adaptive histogram equalization (CLAHE), and adaptive gamma correction—was employed to reduce inter-device variability and standardize retinal appearance. FusionEye-Net was first trained on a curated internal dataset of approximately 4000 images, achieving an internal test accuracy of 99.24%. However, evaluation on an independent external dataset comprising 4640 images revealed a significant performance drop to 72.05%, highlighting the severity of cross-domain variability. To mitigate this degradation, a targeted supervised domain adaptation strategy was applied using a balanced subset of 2000 external images (500 per class). This adaptation improved external performance to 91.27% accuracy with a macro F1-score of 0.9139, reducing misclassifications by more than two-thirds. Model predictions and visual explanations were reviewed by a board-certified retina specialist to ensure clinical plausibility. Explainability analysis using Gradient-weighted Class Activation Mapping (Grad-CAM) and region-of-interest (ROI) contour mapping demonstrated that the adapted model consistently focuses on medically relevant structures, such as lens opacity in cataract, microaneurysms in diabetic retinopathy, and optic disc cupping in glaucoma. In summary, the results demonstrate that FusionEye-Net combines strong internal performance with substantially improved cross-domain generalization through lightweight adaptation, underscoring the critical role of external validation and domain-aware fine-tuning in formulating trustworthy, adaptive AI-assisted decision-support tools that can safely augment automated ophthalmic screening workflows.

Read PDF

Similar papers

Open access Sep 2026

Improving Generalization of Deep Learning for Glaucoma Classification Under Real-World Domain Shift via Unsupervised Domain Adaptation

Purpose To develop and evaluate an unsupervised domain adaptation (UDA) framework for glaucoma classification from fundus images that improves the generalizability of deep learning (DL) models across heterogeneous imaging characteristics and clinical settings. Methods We developed an adversarial UDA framework that adap...

Homa Rashidisabet, R. V. Paul Chan, T. Vajaranant et al. · 0 citations
Jul 2026

High Performance Hybrid CNN CBAM Framework for High Sensitivity Heart Disease Classification

Cardiovascular diseases remain a paramount global health crisis, necessitating early and precise diagnostic interventions. While medical imaging is the clinical standard, manual interpretation is highly susceptible to visual fatigue and inter-observer variability. This study proposes a novel, highly robust Computer-Aid...

Giant Prakoso Amukti Wibowo, Slamet Riyadi, A. Dewi et al. · 0 citations
Open access Sep 2026

PIKER-NET: Multi-class retinal disease classification using Pied Kingfisher optimization-based improved residual network

The proposed PIKER-NET approach has strong clinical relevance by supporting earlier disease screening, reducing misdiagnosis, and enabling faster diagnosis to assist ophthalmologists in improving patient outcomes.

Lissy Devasahayam, Ramya Devi Murugadasan, Anandhi Samuel Vijayalakshmi et al. · 0 citations
Open access Sep 2026

A two-stage deep learning framework with progressive feature fusion and attention mechanisms for multi-class retinal disease classification

Accurate and efficient automated analysis of Optical Coherence Tomography (OCT) images is critical for large-scale retinal disease screening. However, current deep learning models often fail to simultaneously achieve high classification accuracy, practical computational feasibility, and interpretability. To deal with t...

Mithun Vijayan, Goutham Veerapu, N. S. · 0 citations
Open access Sep 2026

Comparative Analysis of CNN and Transformer Models for Multi-Class Diabetic Retinopathy Grading Using Fundus Images

This study systematically compares representative standard and lightweight CNN- and transformer-based architectures for multi-class DR grading and offers practical guidance for selecting suitable deep learning models for automated diabetic retinopathy screening.

Maha A. Thafar · 0 citations
Review Open access Aug 2026

AI-Based Skin Disease Classification Using Deep Learning Techniques

Skin diseases represent one of the most widespread categories of health disorders worldwide, and timely diagnosis plays a critical role in preventing complications such as skin cancer. Conventional diagnostic procedures depend largely on visual examination by dermatologists, a process that is subjective, time-consuming...

Nisha Rajodiya, Shailendra Mishra, Sumitra Menaria et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.